End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,960 CZK | +1.01% | +0.88% | +2.18% |
Mar. 26 | Philip Morris CR a.s. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Philip Morris CR a.s.(SEP:TABAK) dropped from FTSE All-World Index | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The group's high margin levels account for strong profits.
- The company is one of the best yield companies with high dividend expectations.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.18% | 1.86B | - | ||
+1.00% | 148B | B- | ||
+0.28% | 19.29B | A- | ||
+5.54% | 5.38B | B- | ||
+57.08% | 2.07B | - | C+ | |
-8.95% | 1.62B | - | D+ | |
-24.54% | 1.25B | - | B+ | |
0.00% | 660M | - | - | |
+7.29% | 499M | C+ | ||
-17.98% | 440M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TABAK Stock
- Ratings Philip Morris CR